Answers are grounded in this paper and cite their sources.
“Myasthenia gravis” has its origins in Greek. The terms denote muscle weakening (myasthenia) and heaviness (gravis). Myasthenia gravis (myasthenia gravis) is an autoimmune disorder marked by muscle weakness that exacerbates with activity, predominantly impacting the oculobulbar muscles and principally targeting postsynaptic nicotinic acetylcholine receptors. 1 This condition, characterized by a significantly high mortality rate due to respiratory failure, holds unique significance among neuromuscular disorders and within the broader field of neurology, as patients can enjoy perfectly normal lives with appropriate treatment. The prevalence of the condition in women is bimodal, with the highest incidence occurring between the ages of 20-30 and above 50 years. In contrast to males above the age of 50. The disease's most notable characteristic is muscle weakness, which exacerbates with tiredness and is at least partially alleviated by rest. Patients indicate improvement in the morning, with symptoms exacerbating in the evening or when fatigued 2 The manifestation of disease progresses with periods of remission and exacerbation. Remissions can last for durations ranging from a few days to several years.
No takes yet. Share an insight, caveat, or question.
Samnang Khim (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: